CClinicalTrials.gg
CompletedNCT03677232Updated Sep 19, 2018

The Living Experience of Hong Kong Chinese Adolescents With CHD.

An observational study in Congenital Heart Disease, Psychological Well-being and Quality of Life, sponsored by The University of Hong Kong. Completed at 1 site in Hong Kong. Open to participants aged 12 Years to 18 Years. Per ClinicalTrials.gov, last updated 2018-09-19.

Sponsored by The University of Hong Kong · Observational

Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
30
Ages
12 Years to 18 Years
Sex
All
01

Study summary

This study aims to explore the impacts of CHD and its limitations on adolescents and the living experience of adolescents living with CHD.

Hong Kong Chinese adolescents with CHD are having reduced psychological well-being and quality of life than their healthy counterparts. Qualitative study is therefore needed to explore how CHD may impact on the adolescents' psychological well-being and quality of life.

Read the detailed description

A qualitative study was adopted. Purposive sampling of 30 adolescents with CHD were done. Thematic analysis was used for data analysis. The participants unfold negative impacts of CHD and its treatments, and the challenges they were facing with their relationship with others.

02

Conditions studied

  • Congenital Heart Disease
  • Psychological Well-being
  • Quality of Life
  • Adolescent
  • Chinese

Keywords

  • Congenital Heart Disease, Hong Kong, Adolescent
03

In context

Heart Diseases

3,639 studies on the registry are indexed under Heart Diseases; 461 are open to participants now.

This study's enrollment of 30 is below the median of 294 across 1,241 observational studies indexed under Heart Diseases.

Browse Heart Diseases studies →

Lead sponsor

The University of Hong Kong is the lead sponsor of 1,262 studies on the registry; 340 are open to participants now.

Of its 8 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Hong Kong Chinese adolescents with CHD, aged 12 to 18, who are able to read and write Chinese, and are attending the outpatient clinic of Department of Pediatric Cardiology.

Inclusion criteria

  • Hong Kong Chinese adolescents
  • aged 12 to 18
  • able to read and write Chinese
  • attending outpatient clinic of Department of Pediatric Cardiology

Exclusion criteria

Exclusion Criteria:

  • adolescents with non-structural heart disease
  • with developmental delay or comorbid medical conditions
05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
30 participants (actual)
Target follow-up
1 Day
Patient registry
Yes

Groups and cohorts

  • Hong Kong Chinese adolescents with CHD

    Hong Kong Chinese adolescents with CHD aged 12-18 who are able to read and write chinese

06

What researchers measure

Primary outcomes

  1. living experience of adolescents with CHD

    Participants were asked to describe their living experiences with CHD and how has CHD affected their quality of life and psychological well-being during the semi-structure interview.

    Time frame: 1 day

07

Study locations

1 site
  • University of Hong Kong
    Hong Kong, Hong Kong
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 19, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03677232
Lead sponsor
The University of Hong Kong
Responsible party
Dr. LI William Ho Cheung (Associate Professor, The University of Hong Kong) — Principal investigator
First posted
Sep 19, 2018
Start date
Aug 11, 2017
Primary completion
Aug 31, 2018
Completion
Aug 31, 2018
Last update
Sep 19, 2018

Study contacts

William Li, PhD
principal investigator · The University of Hong Kong

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion